Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

172
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
172
Survival Curves01:18

Survival Curves

359
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
359
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

288
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
288
Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

319
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
319
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

420
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
420

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial Activity Patterning and Topological Defect Transport in Acoustically Energized Active Liquid Crystals.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Diffractive wavefront correction for Fe L-edge spectroscopy on the meV scale.

Journal of synchrotron radiation·2026
Same author

Characterization and fabrication of high-performance B<sub>4</sub>C-coated mirrors for X-ray free-electron lasers.

Applied optics·2026
Same author

Leveraging Auxiliary Potentials in RFDiffusion for the Design of NA-Binding Proteins.

Journal of chemical information and modeling·2026
Same author

Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma.

PeerJ·2026
Same author

scRNA-seq of preeclamptic trophoblasts identifies EBI3, COL17A1, miR-27a-5p, and miR-193b-5p as hypoxia markers: validation of neuradapt as a superior mimetic to cobalt chloride.

Placenta·2026

Related Experiment Video

Updated: Sep 28, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K

ExhauFS: exhaustive search-based feature selection for classification and survival regression.

Stepan Nersisyan1, Victor Novosad1,2, Alexei Galatenko3,4

  • 1Faculty of Biology and Biotechnology, HSE University, Moscow, Russia.

Peerj
|April 5, 2022
PubMed
Summary

ExhauFS, a new tool for exhaustive feature selection, accurately identifies gene and isomiR signatures for cancer patient classification and survival prediction. It outperforms other methods in cross-platform validation for breast and colorectal cancer datasets.

Keywords:
ClassificationExhauFSExhaustive searchFeature selectionSurvival regression

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

929
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Related Experiment Videos

Last Updated: Sep 28, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

929
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Area of Science:

  • Bioinformatics
  • Machine Learning
  • Computational Biology

Background:

  • Feature selection is crucial for preventing overfitting in machine learning.
  • Exhaustive search is an effective but often unavailable feature selection method.
  • Biomedical research lacks accessible implementations for exhaustive feature selection.

Purpose of the Study:

  • To introduce ExhauFS, a user-friendly command-line tool for exhaustive feature selection.
  • To demonstrate ExhauFS's utility in classification and survival regression tasks.
  • To benchmark ExhauFS against state-of-the-art methods in real-world cancer datasets.

Main Methods:

  • Exhaustive search algorithm implemented in ExhauFS.
  • Application of ExhauFS for gene signature construction in breast cancer recurrence prediction.
  • Utilizing ExhauFS for isomiR signature development in colorectal cancer survival analysis.
  • Benchmarking ExhauFS against L1-regularized models.

Main Results:

  • ExhauFS successfully constructed gene signatures for breast cancer with high sensitivity and specificity.
  • Identified cross-platform gene signatures for breast cancer recurrence prediction.
  • Developed predictive isomiR signatures for colorectal cancer survival with good concordance index.
  • ExhauFS outperformed alternative methods in cross-platform validation and predictive accuracy.

Conclusions:

  • ExhauFS provides a robust and accessible solution for exhaustive feature selection in biomedical research.
  • The tool enables the discovery of reliable and cross-platform predictive signatures.
  • ExhauFS demonstrates superior performance compared to existing feature selection approaches for cancer-related datasets.